Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
本土病例440例 new symptomatic cases (Sichuan 四川128例 and Heilongjiang 黑龙江67例 and Tibet 西藏65例 and Hainan 海南40例 and Guangdong 广东65例 and Shaanxi 陕西8例)
本土1379例 new asymptomatic cases (Tibet 西藏524例 and Sichuan 四川74例 and Qinghai 青海104例 and Heilongjiang 黑龙江168例 and Shandong 山东75例 and Hainan 海南29例 and Liaoning 辽宁116例 and Tianjin 天津18例 and Xinjiang 新疆35例 and Henan 河南40例 and Shaanxi 陕西11例 and Guangxi 广西9例)
本土1379例 new asymptomatic cases (Tibet 西藏524例 and Sichuan 四川74例 and Qinghai 青海104例 and Heilongjiang 黑龙江168例 and Shandong 山东75例 and Hainan 海南29例 and Liaoning 辽宁116例 and Tianjin 天津18例 and Xinjiang 新疆35例 and Henan 河南40例 and Shaanxi 陕西11例 and Guangxi 广西9例)
What's up @Yommie
本土病例314例 new symptomatic cases (Sichuan 四川98例 and Guangdong 广东79例 and Tibet 西藏51例 and Hainan 海南24例 and Liaoning 辽宁11例)
本土1359例 new asymptomatic cases (Tibet 西藏505例 and Sichuan 四川88例 and Qinghai 青海131例 and Heilongjiang 黑龙江93例 and Shandong 山东78例 and Hainan 海南21例 and Liaoning 辽宁113例 and Tianjin 天津19例 and Xinjiang 新疆33例 and Henan 河南17例 and Shaanxi 陕西8例 and Guangxi 广西18例)
本土1359例 new asymptomatic cases (Tibet 西藏505例 and Sichuan 四川88例 and Qinghai 青海131例 and Heilongjiang 黑龙江93例 and Shandong 山东78例 and Hainan 海南21例 and Liaoning 辽宁113例 and Tianjin 天津19例 and Xinjiang 新疆33例 and Henan 河南17例 and Shaanxi 陕西8例 and Guangxi 广西18例)
It's not gonna matter that much, most people dun bother to get tested or isolate nowadays. Testing numbers are way down. Masks on street is definitely in minority. And mostly just elderly and Asians from overseas still bother to wear them. Masks on public transportation is still required but less than 50% still do it.
The winter wave has eased slightly, I think daily deaths will average about 25-35 for Aus, but some states dun bother reporting statistics so it's hard to get accurate figures. Hospitalization figures did not drop a lot, medical staff are pretty overworked, some are still on strike as far as I know.
Last edited:
"Just one breath": China approves world's 1st inhaled COVID-19 vaccine
The logo of CanSino Biologics is seen in Shanghai, China, August 11, 2022. /CFP
The world's first has been approved by National Medical Products Administration of China (NMPA) to be used as a booster dose, the developer CanSino Biologics said on Sunday.
The vaccine, named "Convidecia Air," is the inhaled version of the Tianjin-based company's adenoviral vector vaccine, Convidecia.
It "provides a non-invasive option" for people who prefer not to take a jab, the company said, adding that the new vaccine can establish immunity against COVID-19 after "just one breath."
The company said the Phase III trail results published in the medical journal The Lancet indicate that the new vaccine is can induce strong humoral, cellular and mucosal immunity to achieve triple protection and effectively contain the infection and spread of the virus.
There are many kinds of COVID-19 vaccines from different companies available in China, including Convidecia. More than 3.4 billion COVID-19 vaccine doses have been taken in the Chinese mainland, according to data from the National Health Commission (NHC).
The Chinese mainland has collectively reported 244,708 COVID-19 cases since late 2019, NHC data also showed. Among them, 233,284 have recovered and 5,226 passed away.